文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

肠道微生物组与代谢组改变与脓毒症临床结局相关

Altered intestinal microbiome and metabolome correspond to the clinical outcome of sepsis.
PubMed 文献 · Crit Care · 2023-03-28
一句话结论脓毒症患者肠道共生菌破坏、肠球菌丰度升高,高拟杆菌负荷(尤其B. vulgatus)与更高APACHE II评分和更长ICU停留相关,色氨酸代谢与菌群改变及病情严重程度密切相关。

本研究联合微生物组与非靶向代谢组学分析脓毒症患者入院时的粪便样本,筛选与疾病结局相关的菌群、代谢物及潜在信号通路,并在脓毒症动物模型中以微生物组和转录组学验证。结果显示脓毒症患者共生菌群破坏、肠球菌丰度升高,动物实验验证;高拟杆菌负荷(尤其B. vulgatus)患者APACHE II评分更高、ICU停留更长;CLP大鼠肠道转录组显示肠球菌与拟杆菌与差异表达基因的相关性模式不同。脓毒症患者肠道氨基酸代谢紊乱,色氨酸代谢与菌群改变及脓毒症严重程度紧密相关。

要点

  • 脓毒症患者肠道共生菌群破坏,肠球菌丰度升高,动物实验验证。
  • 高拟杆菌负荷(尤其B. vulgatus)的脓毒症患者APACHE II评分更高、ICU停留时间更长。
  • CLP大鼠肠道转录组显示肠球菌与拟杆菌和差异表达基因的相关性模式不同,提示二者在脓毒症中作用不同。
  • 脓毒症患者肠道氨基酸代谢紊乱,色氨酸代谢与菌群改变及脓毒症严重程度紧密相关。
  • 微生物与代谢特征改变与脓毒症进展对应,可能有助于早期预测临床结局并为探索新疗法提供转化基础。

适用人群与场景

  • 入院时纳入的脓毒症患者,采集粪便样本;对照为健康对照。
  • 动物模型为CLP大鼠脓毒症模型。

研究设计与关键结果

  • 研究采用微生物组与非靶向代谢组学联合分析脓毒症患者入院时粪便样本,筛选与疾病结局相关的菌群、代谢物及潜在信号通路,并在脓毒症动物模型中以微生物组和转录组学验证。
  • 脓毒症患者表现为共生菌群破坏和肠球菌丰度升高,该结果在动物实验中得到验证。
  • 高拟杆菌负荷(尤其B. vulgatus)的脓毒症患者急性生理与慢性健康评估II评分更高、重症监护室停留时间更长。
  • CLP大鼠肠道转录组显示肠球菌和拟杆菌与差异表达基因的相关性模式不同,提示这两种细菌在脓毒症中作用不同。
  • 与健康对照相比,脓毒症患者肠道氨基酸代谢紊乱,其中色氨酸代谢与菌群改变及脓毒症严重程度紧密相关。

证据类型、等级与局限

  • 研究类型:微生物组与非靶向代谢组学联合分析,并在动物模型中以微生物组和转录组学验证。
  • 局限:原文未报告局限性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The gut microbiome plays a pivotal role in the progression of sepsis. However, the specific mechanism of gut microbiota and its metabolites involved in the process of sepsis remains elusive, which limits its translational application.

METHOD: In this study, we used a combination of the microbiome and untargeted metabolomics to analyze stool samples from patients with sepsis enrolled at admission, then microbiota, metabolites, and potential signaling pathways that might play important roles in disease outcome were screened out. Finally, the above results were validated by the microbiome and transcriptomics analysis in an animal model of sepsis.

RESULTS: Patients with sepsis showed destruction of symbiotic flora and elevated abundance of Enterococcus, which were validated in animal experiments. Additionally, patients with a high burden of Bacteroides, especially B. vulgatus, had higher Acute Physiology and Chronic Health Evaluation II scores and longer stays in the intensive care unit. The intestinal transcriptome in CLP rats illustrated that Enterococcus and Bacteroides had divergent profiles of correlation with differentially expressed genes, indicating distinctly different roles for these bacteria in sepsis. Furthermore, patients with sepsis exhibited disturbances in gut amino acid metabolism compared with healthy controls; namely, tryptophan metabolism was tightly related to an altered microbiota and the severity of sepsis.

CONCLUSION: Alterations in microbial and metabolic features in the gut corresponded with the progression of sepsis. Our findings may help to predict the clinical outcome of patients in the early stage of sepsis and provide a translational basis for exploring new therapies.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Sun S, Wang D, Dong D, et al. Altered intestinal microbiome and metabolome correspond to the clinical outcome of sepsis. Crit Care. 2023. PMID: 36978107. doi:10.1186/s13054-023-04412-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。